Vaylen
Semaglutide, oral tablets and tirzepatide from $83.25/mo.
Overview
Vaylen is a cash-pay telehealth weight loss program built on compounded GLP-1 medication, sold in three formats across two molecules: weekly semaglutide injections from $83.25/mo, daily oral semaglutide tablets from $99/mo, and weekly tirzepatide from $149/mo. Every headline rate is an annualized price on a 12-month plan billed upfront, and you pay before a clinician reviews your health form, with a full refund if you are declined. Cash-pay compounded GLP-1 in three formats, from $83.25/mo on the 12-month plan. Full Refund If Not Approved | Full Refund If Not Approved | Save big now. Same price every month! Starting at $83/mo with a 12-month plan. | Was $224 | Now starting at$83 | 12‑month | Same price every month. | Telehealth consultations included, by live video or asynchronous review. No insurance required. Prescription fulfillment included if clinically appropriate. | Same price every month. No hikes, at every dosage level. | Free discreet shipping in 1–3 days. | ✓ Cancel anytime | ✓ Full refund if not approved | Licensed in 50 States | Full Refund If Not Approved | No Insurance Required | Same Price Every Month | Cancel Anytime | Licensed in 50 States | Full Refund If Not Approved | No Insurance Required | Same Price Every Month | Cancel Anytime | Three leading GLP-1 treatments. Injectable or tablet. Semaglutide or tirzepatide. Your clinician helps you choose the right one after reviewing your health. | Semaglutide Injectable | Semaglutide injectable. Once weekly. The same active ingredient as Ozempic. Average 15% body weight loss over 12 months. | Tirzepatide injectable. Once weekly. Dual GLP-1 and GIP action. The same active ingredient as Zepbound. Average 20% body weight loss. | Semaglutide tablet. Daily dissolvable. No needle. Same active ingredient delivered orally. | Start treatment from $83/mo Treatment is available only when a licensed clinician determines it is medically appropriate. Compounded medications, when offered, are not FDA-approved and are not reviewed…
Pros
- Both molecules and a needle-free format on one platform, so a clinician can switch you without changing providers
- $83.25/mo on the 12-month semaglutide program, among the lowest effective rates in cash-pay GLP-1 care
- Oral semaglutide at $99/mo prepaid undercuts most oral GLP-1 pricing in the compounded market
- A published refund if the clinician declines to prescribe, which de-risks the pay-first model
- $0 consultation fee, with the clinician review bundled into every plan price
- Clinician review turned around within 24 hours, and shipping in 1 to 3 business days
- Injection kit, free discreet shipping, and 24/7 care-team messaging included, not upsold
- LegitScript certified, HIPAA protected, licensed U.S. clinicians via OpenLoop Health in all 50 states
Cons
- You pay before any clinician sees your file, the reverse of the free-evaluation model most competitors use
- Every headline rate requires prepaying a full year in one charge, up to $1,788 for tirzepatide
- No published terms for the unused portion of a prepaid year if you cancel mid-treatment
- The needle-free tablet costs about $16/mo more than the injection of the same molecule
- Prepay discounts shrink as prices rise, 50% on tirzepatide against 62% on semaglutide
- All medications are compounded, not FDA-approved finished products, with no branded pathway offered
- Patient before-and-after figures are reused across different product pages
- Cash-pay only, with no insurance offset
Features
- Compounded semaglutide, oral tablets, and tirzepatide on one platform
- $0 consultation fee, clinician review within 24 hours
- Free discreet shipping in 1 to 3 business days
- Full refund for that billing cycle if the clinician declines to prescribe
- LegitScript certified, licensed U.S. clinicians via OpenLoop Health
- Available in all 50 states, HIPAA protected
Vaylen FAQ
How much does Vaylen cost?
Vaylen publishes two prices for each of its three GLP-1 options. Semaglutide injections are $83.25/mo on the 12-month program or $224/mo month to month. Oral semaglutide tablets are $99/mo on the 12-month program or $249/mo monthly. Tirzepatide injections are $149/mo on the 12-month program or $299/mo monthly. Every 12-month rate is billed upfront in a single charge, which works out to $999, $1,188, and $1,788 respectively.
Do I pay Vaylen before seeing a doctor?
Yes, and Vaylen is upfront that this is deliberate. You start the subscription first, then complete a short health questionnaire. A board-certified U.S. clinician reviews your answers within 24 hours. If the clinician decides GLP-1 medication is not clinically appropriate, Vaylen states you receive a full refund for that billing cycle.
Does Vaylen have an oral GLP-1 you can take without needles?
Yes. Vaylen offers oral semaglutide as one small dissolvable tablet taken daily, with the same active ingredient as its weekly injection. It costs $99/mo on the prepaid 12-month program or $249/mo month to month, a premium of roughly $16/mo over the injectable version of the same molecule.
Is Vaylen semaglutide FDA-approved?
No. Vaylen states in its own disclosures that compounded medications are not FDA-approved finished products and have not been evaluated by the FDA for safety, efficacy, or quality. They are prepared by licensed U.S. pharmacies against an individual prescription.
Customer Reviews
No customer reviews yet. Be the first to review.